Logotype for Laurus Labs Ltd

Laurus Labs (LAURUSLABS) investor relations material

Laurus Labs Q1 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Laurus Labs Ltd
Q1 25/26 earnings summary25 Jul, 2025

Executive summary

  • Q1 FY26 revenues reached ₹1,570 Cr, marking 31% year-over-year growth, driven by strong CDMO and generics expansion, with robust formulation business growth and major capacity expansions.

  • EBITDA stood at ₹389 Cr with a margin of 24.8%, up 10.5 percentage points year-over-year due to CDMO ramp-up and operating leverage.

  • Gross margins improved to 59.4% on a favorable product mix and process improvements.

  • Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, with no material misstatements reported.

  • Continued investments in manufacturing and specialized modalities, with CAPEX at 17% of sales.

Financial highlights

  • Revenue reached ₹1,570 Cr, up 31% year-over-year, but declined 9% sequentially from Q4 FY25.

  • Gross margin expanded to 59.4%, up over 4 percentage points year-over-year and 4.9 sequentially.

  • EBITDA margin rose by 10.5 percentage points to 24.8%, reflecting better operating leverage.

  • Net profit after tax for Q1 was ₹163 Cr, up 1,154% year-over-year.

  • Net debt stood at ₹2,003 Cr, with net debt/EBITDA at 1.8, down from 2.3 last quarter.

Outlook and guidance

  • Management expects gross margins to remain in the 55–60% range as CDMO share increases.

  • Asset turnover is expected to normalize over the next two years as new CDMO projects ramp up.

  • Ongoing CAPEX and facility expansions are set to enhance service capabilities in advanced modalities and fermentation.

  • Non-ARV formulations capacity expansion to drive growth from Q4 onwards.

  • ARV segment guidance remains cautious due to price drop risks, with incremental volumes expected to offset declines.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Laurus Labs earnings date

Logotype for Laurus Labs Ltd
Q2 25/2623 Oct, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Laurus Labs earnings date

Logotype for Laurus Labs Ltd
Q2 25/2623 Oct, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Laurus Labs Limited, a pharmaceutical company, develops, manufactures, and sells active pharmaceutical ingredients (APIs) and formulations in India. It involves in the development of antiviral APIs; generic APIs for hepatitis C and HIV Darunavir tablets; and oncology BCS class II drugs. The company also develops and commercializes single super specialty products comprising linezolid and formoterol. The company was incorporated in 2005 and is based in Hyderabad, India.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage